January 29, 2016
Roche annual profit disappoints, outlook muted
Cancer drug maker Roche followed Swiss rival Novartis in disappointing shareholders with a muted forecast for the year, sending its shares lower on Thursday.
Pharmaceuticals, Biotechnology and Life Sciences
Tag: financial